Feedback / Questions
Yervoy (ipilimumab) - Ono Pharma, BMS
anti-PD-1 antibody - Premier Biomedical
Keytruda (pembrolizumab) - Merck (MSD)
anti-CTLA4 antibody - Abzena
https://www.ajmc.com/view/pros-and-cons-of-immunotherapy-in-metastatic-nsclc
David Carbone; Martin Dietrich
Nov 9, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next